Molecular therapy for pulmonary arterial hypertension: Icariin, a flavanoid and phosphodiestrase-5 inhibitor, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 18/April/2015, 17.35

An important info related to Terms and conditions
April 18, 2015
Vitamin-based Life-span extension therapy: α-Tocotrienol, a natural form of Vitamin-E, increases the expression of longevity-promoting and antiaging gene Klotho via down regulation of its target gene, 18/April/2015, 18.20
April 18, 2015
Show all

A study from the University of California, La Jolla, California, USA shows that Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General Medicine with an I.F of 28.054] by Prof. Thistlethwaite PA, Li X and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for pulmonary arterial hypertension: Icariin inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3

Significance: This study suggests, for the first time, that Icariin, by increasing the expression of its target gene, it may decrease the expression of Notch3. Thus, pharmacological formulations encompassing Icariin or its analogues” may be used to treat pulmonary arterial hypertension.

Amount: $ 500*

Undisclosed information: How Icariin decreases the expression of Notch3 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular therapy for pulmonary arterial hypertension: Icariin, a flavanoid and phosphodiestrase-5 inhibitor, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 18/April/2015,  17.35,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.